# reload+after+2024-01-20 14:33:35.020563
address1§14 Hakitor Street
address2§Haifa Bay
city§Haifa
zip§2624761
country§Israel
phone§972 4 847 5700
website§https://www.taro.com
industry§Drug Manufacturers—Specialty & Generic
sector§Healthcare
longBusinessSummary§Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage form products. It offers its products for various therapeutic categories comprising allergy, analgesic, antibacterial, antibiotic, anticonvulsant, antiemetic, antifungal, anti-inflammatory, anti-cancer, antiplatelet agent, antipyretic, cardiovascular, CNS, corticosteroid, cosmetic, cough and cold, dermatology, diuretic, endocrine, gastrointestinal, laxative, narcotics, neuropathic pain, neuropsychiatric, sedative/hypnotic, and topical anti-neoplastic. The company provides its products in the form of capsule, cream, drops, emulsion, gel/gel kit, granules, injectable, lotion, oil, ointment, paste, powder/powder for solution, rectal suppository, shampoo, solution/solution for infusion, spray, suspension, syrup, tablets, toothpaste and mouthwash, topical foam, and topical solution. It distributes and sells its products directly to wholesalers, retail drug chains, food chains, hospitals, mass merchandisers, e-commerce stores, and other direct consumers, as well as healthcare institutions and private pharmacies. The company was incorporated in 1959 and is based in Haifa, Israel. Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Alkaloida Chemical Company Zrt. As of June 30, 2023, Taro Pharmaceutical Industries Ltd. operates as a subsidiary of Sun Pharmaceutical Industries Limited.
fullTimeEmployees§1554
companyOfficers§[{'maxAge': 1, 'name': 'Mr. Uday V. Baldota', 'age': 53, 'title': 'CEO & Director', 'yearBorn': 1970, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. William J. Coote', 'age': 68, 'title': 'VP, CFO & Chief Accounting Officer', 'yearBorn': 1955, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Itamar  Karsenti', 'age': 51, 'title': 'VP & Head of Operations', 'yearBorn': 1972, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Avi  Avramoff', 'age': 58, 'title': 'VP and Head of R&D', 'yearBorn': 1965, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Itzik  Baruch', 'age': 60, 'title': 'Vice President of Technical Services', 'yearBorn': 1963, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Dr. Roman  Kaplan', 'age': 76, 'title': 'Vice President of Scientific and Technical Compliance Manager', 'yearBorn': 1947, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Erik  Zwicker J.D.', 'age': 43, 'title': 'VP, General Counsel & Secretary', 'yearBorn': 1980, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Ara  Aprahamian', 'age': 55, 'title': 'Vice President of Sales & Marketing', 'yearBorn': 1968, 'fiscalYear': 2017, 'totalPay': 616143, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Ms. Michele  Visosky', 'age': 57, 'title': 'VP & Head of Human Resource', 'yearBorn': 1966, 'fiscalYear': 2017, 'exercisedValue': 0, 'unexercisedValue': 0}, {'maxAge': 1, 'name': 'Mr. Jayesh  Shah', 'age': 67, 'title': 'Head of Procurement', 'yearBorn': 1956, 'fiscalYear': 2017, 'exercisedValue': 0, 'unexercisedValue': 0}]
compensationAsOfEpochDate§1514678400
maxAge§86400
priceHint§2
exDividendDate§1544400000
payoutRatio§0.0
beta§0.662
priceToSalesTrailing12Months§2.6244593
currency§USD
dateShortInterest§1702598400
forwardEps§4.39
pegRatio§-2.92
exchange§NYQ
quoteType§EQUITY
shortName§Taro Pharmaceutical Industries 
longName§Taro Pharmaceutical Industries Ltd.
firstTradeDateEpochUtc§400858200
timeZoneFullName§America/New_York
timeZoneShortName§EST
uuid§040d0949-c458-32a8-b189-a0bfe3d2d7e2
gmtOffSetMilliseconds§-18000000
recommendationMean§2.0
recommendationKey§buy
quickRatio§3.138
grossMargins§0.46795
ebitdaMargins§0.06916
trailingPegRatio§None
